I see that the prevailing view on IH is that no "e

I see that the prevailing view on IH is that no "emergency use authorization" is coming. So I was probably too optimistic. But here's what I don't understand -- why would the FDA have allowed Leronlimab to be used for 30 or so EIND critically ill patients, if not to hopefully save lives? And if the FDA was hoping that Leronlimab would save lives (which Leronlimab then actually accomplished), then why not grant "emergency use authorization" to Leronlimab in order to save more lives of critically ill patients? I just don't understand!